A detailed history of Black Rock Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,965,413 shares of IDYA stock, worth $215 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,965,413
Previous 5,436,668 9.73%
Holding current value
$215 Million
Previous $193 Million 35.32%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$34.2 - $47.13 $18.1 Million - $24.9 Million
528,745 Added 9.73%
5,965,413 $262 Million
Q4 2023

Feb 13, 2024

BUY
$24.59 - $35.83 $20.7 Million - $30.2 Million
843,095 Added 18.35%
5,436,668 $193 Million
Q3 2023

Nov 13, 2023

BUY
$21.07 - $29.77 $5.01 Million - $7.08 Million
237,877 Added 5.46%
4,593,573 $124 Million
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $10.8 Million - $20.6 Million
806,603 Added 22.73%
4,355,696 $102 Million
Q1 2023

May 12, 2023

BUY
$13.49 - $18.72 $166,776 - $231,435
12,363 Added 0.35%
3,549,093 $48.7 Million
Q4 2022

Feb 13, 2023

BUY
$14.47 - $18.17 $12.5 Million - $15.6 Million
861,174 Added 32.19%
3,536,730 $64.3 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $492,196 - $841,101
53,268 Added 2.03%
2,675,556 $39.9 Million
Q2 2022

Aug 12, 2022

BUY
$8.28 - $13.88 $1.09 Million - $1.83 Million
132,011 Added 5.3%
2,622,288 $36.2 Million
Q1 2022

May 12, 2022

SELL
$11.18 - $24.02 $2.68 Million - $5.75 Million
-239,442 Reduced 8.77%
2,490,277 $27.9 Million
Q4 2021

Feb 10, 2022

SELL
$20.95 - $26.88 $5.91 Million - $7.58 Million
-281,947 Reduced 9.36%
2,729,719 $64.5 Million
Q3 2021

Nov 09, 2021

BUY
$17.26 - $27.08 $7.06 Million - $11.1 Million
409,243 Added 15.73%
3,011,666 $76.8 Million
Q2 2021

Aug 11, 2021

BUY
$17.76 - $24.83 $46.2 Million - $64.6 Million
2,602,423 New
2,602,423 $54.6 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.74B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.